DETECTION OF LYMPH-NODE METASTASES OF SQUAMOUS-CELL CANCER OF THE HEAD AND NECK WITH FDG-PET AND MRI

  • JW BRAAMS*
  • , J PRUIM
  • , NJM FRELING
  • , PGJ NIKKELS
  • , JLN ROODENBURG
  • , G BOERING
  • , W VAALBURG
  • , A VERMEY
  • *Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    254 Citations (Scopus)

    Abstract

    The uptake of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a squamous-cell carcinoma of the oral cavity was studied with PET in order to detect and locate lymphogenic metastases. Methods: The results of FDG-PET imaging were compared with clinical, MRI and histopathologic findings. Standardized uptake values (SUV) were also calculated. Results: A sensitivity of 91% and a specificity of 88% were calculated for FDG-PET. In contrast, a sensitivity of 36% and a specificity of 94% were calculated for MRI. Calculated SUVs for reactive lymph nodes, metastatic lymph nodes and the primary tumor were undifferentiated. Conclusion: Using FDG-PET, lymph node metastases of squamous-cell carcinomas of the oral cavity can be visualized with a high sensitivity and specificity. FDG-PET can be an improvement in the evaluation of the neck.

    Original languageEnglish
    Pages (from-to)211-216
    Number of pages6
    JournalJournal of Nuclear Medicine
    Volume36
    Issue number2
    Publication statusPublished - Feb-1995

    Keywords

    • PET
    • FLUORODEOXYGLUCOSE
    • MRI
    • HEAD AND NECK METASTASES
    • POSITRON EMISSION TOMOGRAPHY
    • F-18 FLUORODEOXYGLUCOSE
    • INTRATUMORAL DISTRIBUTION
    • FLOW-CYTOMETRY
    • TUMORS
    • TISSUES
    • INVIVO
    • BRAIN

    Fingerprint

    Dive into the research topics of 'DETECTION OF LYMPH-NODE METASTASES OF SQUAMOUS-CELL CANCER OF THE HEAD AND NECK WITH FDG-PET AND MRI'. Together they form a unique fingerprint.

    Cite this